Article Text

Download PDFPDF
Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol
  1. Simon Godfrey,
  2. Peter König


    Twenty-six children with asthma were treated with beclomethasone dipropionate aerosol in a dose adjusted to their symptoms for 13 to 20 months. 18 children in the group had been taking systemic steroids at the start of the trial and all were successfully weaned off them, mostly within 2 months. All but 1 of the children were satisfactorily controlled by beclomethasone, but 15 children needed short courses of oral steroids at times of severe exacerbations.

    There was no evidence of either suppression or acceleration of growth, nor was there any adrenal suppression as assessed at intervals by the estimation of the resting level of plasma cortisol and the response to tetracosactrin. No other side effects were encountered apart from exacerbations of eczema or rhinitis in some children previously on systemic steroids.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.